These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 29421697)

  • 1. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
    Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
    Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.
    Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM
    Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors.
    Chaudhry F; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Munir R; Sohail R; Jahan B; Munawar MA; Khan MA
    Bioorg Chem; 2017 Aug; 73():1-9. PubMed ID: 28521172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
    Wang G; He D; Li X; Li J; Peng Z
    Bioorg Chem; 2016 Apr; 65():167-74. PubMed ID: 26964016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of α-glucosidases.
    Zawawi NK; Taha M; Ahmat N; Ismail NH; Wadood A; Rahim F; Rehman AU
    Bioorg Chem; 2015 Dec; 63():36-44. PubMed ID: 26432614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, molecular docking and α-glucosidase inhibition of 5-aryl-2-(6'-nitrobenzofuran-2'-yl)-1,3,4-oxadiazoles.
    Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Saad SM; Khan KM; Nasir A
    Bioorg Chem; 2016 Jun; 66():117-23. PubMed ID: 27149363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
    Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
    Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
    Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, α-glucosidase inhibitory activity and in silico study of tris-indole hybrid scaffold with oxadiazole ring: As potential leads for the management of type-II diabetes mellitus.
    Taha M; Rahim F; Imran S; Ismail NH; Ullah H; Selvaraj M; Javid MT; Salar U; Ali M; Khan KM
    Bioorg Chem; 2017 Oct; 74():30-40. PubMed ID: 28750203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
    Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
    Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
    Wang G; Wang J; He D; Li X; Li J; Peng Z
    Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxindole based oxadiazole hybrid analogs: Novel α-glucosidase inhibitors.
    Taha M; Imran S; Rahim F; Wadood A; Khan KM
    Bioorg Chem; 2018 Feb; 76():273-280. PubMed ID: 29223804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li J; Li X
    Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel five-step synthetic route to 1,3,4-oxadiazole derivatives with potent α-glucosidase inhibitory potential and their in silico studies.
    Iftikhar M; Shahnawaz ; Saleem M; Riaz N; Aziz-Ur-Rehman ; Ahmed I; Rahman J; Ashraf M; Sharif MS; Khan SU; Htar TT
    Arch Pharm (Weinheim); 2019 Dec; 352(12):e1900095. PubMed ID: 31544284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, In vitro α-Glucosidase Inhibitory Potential and Molecular Docking Studies of 2-Amino-1,3,4-Oxadiazole Derivatives.
    Ullah H; Rahim F; Taha M; Hussain R; Wadood A; Nawaz M; Wahab Z; Kanwal ; Khan KM
    Med Chem; 2020; 16(6):724-734. PubMed ID: 31195948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pyridine-2,4,6-tricarbohydrazide thiourea compounds as small key organic molecules for the potential treatment of type-2 diabetes mellitus: In vitro studies against yeast α- and β-glucosidase and in silico molecular modeling.
    Rehman TU; Riaz S; Khan IU; Ashraf M; Bajda M; Gawalska A; Yar M
    Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29194730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxadiazoles and thiadiazoles: novel α-glucosidase inhibitors.
    Kashtoh H; Hussain S; Khan A; Saad SM; Khan JA; Khan KM; Perveen S; Choudhary MI
    Bioorg Med Chem; 2014 Oct; 22(19):5454-65. PubMed ID: 25151088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel synthesis of dihydropyrimidines for α-glucosidase inhibition to treat type 2 diabetes: in vitro biological evaluation and in silico docking.
    Yar M; Bajda M; Shahzadi L; Shahzad SA; Ahmed M; Ashraf M; Alam U; Khan IU; Khan AF
    Bioorg Chem; 2014 Jun; 54():96-104. PubMed ID: 24880489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of α-glucosidase inhibiting potentials with docking calculations of synthesized arylidene-pyrazolones.
    Chaudhry F; Naureen S; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Jahan B; Hyder Khan M; Iqbal F; Ali Munawar M; Ain Khan M
    Bioorg Chem; 2018 Apr; 77():507-514. PubMed ID: 29454828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.